col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


50 Results       Page 1

 [1] 
Life Science Alliance: Life Science Alliance
  original article Date Title Authors   All Authors
1 [GO] 2024―Sep―17 Clonal landscape of autoantibody-secreting plasmablasts in COVID-19 patients Shuhei Sakakibara, Yu-Chen Liu, Masakazu Ishikawa, Ryuya Edahiro, Yuya Shirai, Soichiro Haruna, et al. (+24)
2 [GO] 2024―Feb―22 Cholesterol and COVID-19-therapeutic opportunities at the host/virus interface during cell entry Thomas Grewal, Mai Khanh Linh Nguyen, Christa Buechler
3 [GO] 2024―Feb―05 Stability of gut microbiome after COVID-19 vaccination in healthy and immuno-compromised individuals Rebecca H Boston, Rui Guan, Lajos Kalmar, Sina Beier, Emily C Horner, Nonantzin Beristain-Covarrubias, et al. (+21)
4 [GO] 2024―Jan―23 Integrated analysis of RNA-seq datasets reveals novel targets and regulators of COVID-19 severity Thais Teixeira Oliveira, Júlia Firme Freitas, Viviane Priscila Barros de Medeiros, Thiago Jesus da Silva Xavier, Lucymara Fassarella Agnez-Lima
5 [GO] 2023―Nov―02 Suppressed transcript diversity and immune response in COVID-19 ICU patients: a longitudinal study Priyanka Mehta, Partha Chattopadhyay, Ramakant Mohite, Ranit D’Rozario, Purbita Bandopadhyay, Jafar Sarif, et al. (+3)
6 [GO] 2023―Sep―25 Comparative analysis of bioinformatics tools to characterize SARS-CoV-2 subgenomic RNAs Denise Lavezzari, Antonio Mori, Elena Pomari, Michela Deiana, Antonio Fadda, Luca Bertoli, et al. (+7)
7 [GO] 2023―Sep―12 Identification of new drugs to counteract anti-spike IgG-induced hyperinflammation in severe COVID-19 Chiara E Geyer, Hung-Jen Chen, Alexander P Bye, Xue D Manz, Denise Guerra, Tom G Caniels, et al. (+13)
8 [GO] 2023―Sep―05 Inhibition of the SREBP pathway prevents SARS-CoV-2 replication and inflammasome activation Vinicius Cardoso Soares, Suelen Silva Gomes Dias, Julia Cunha Santos, Isaclaudia G Azevedo-Quintanilha, Isabela Batista Gonçalves Moreira, Carolina Q Sacramento, et al. (+6)
9 [GO] 2023―Jul―04 Disulfide stabilization reveals conserved dynamic features between SARS-CoV-1 and SARS-CoV-2 spikes Xixi Zhang, Zimu Li, Yanjun Zhang, Yutong Liu, Jingjing Wang, Banghui Liu, et al. (+11)
10 [GO] 2023―Jul―04 ACE2-EGFR-MAPK signaling contributes to SARS-CoV-2 infection Melanie Engler, Dan Albers, Pascal Von Maltitz, Rüdiger Groß, Jan Münch, Ion Cristian Cirstea
11 [GO] 2023―Jun―05 STING is redundant for host defense and pathology of COVID-19-like disease in mice Giorgia Marino, Baocun Zhang, Alexander Schmitz, Hanna VF Schwensen, Line S Reinert, Søren R Paludan
12 [GO] 2023―Apr―11 Intranasal soluble ACE2 improves survival and prevents brain SARS-CoV-2 infection Luise Hassler, Jan Wysocki, Jared T Ahrendsen, Minghao Ye, Ian Gelarden, Vlad Nicolaescu, et al. (+10)
13 [GO] 2023―Mar―28 Reduced replication but increased interferon resistance of SARS-CoV-2 Omicron BA.1 Rayhane Nchioua, Annika Schundner, Susanne Klute, Lennart Koepke, Maximilian Hirschenberger, Sabrina Noettger, et al. (+11)
14 [GO] 2023―Mar―20 Potency assessment of IFNγ-producing SARS-CoV-2-specific T cells from COVID-19 convalescent subjects Rubén Gil-Bescós, Ainhoa Ostiz, Saioa Zalba, Ibai Tamayo, Eva Bandrés, Elvira Rojas-de-Miguel, et al. (+3)
15 [GO] 2023―Feb―20 Plasma proteome dynamics of COVID-19 severity learnt by a graph convolutional network of multi-scale topology Samy Gauthier, Alexy Tran-Dinh, Ian Morilla
16 [GO] 2022―Dec―13 Hyperactive immature state and differential CXCR2 expression of neutrophils in severe COVID-19 Christopher M Rice, Philip Lewis, Fernando M Ponce-Garcia, Willem Gibbs, Sarah Groves, Drinalda Cela, et al. (+11)
17 [GO] 2022―Nov―29 PandemicVibrio choleraeacquired competitive traits from an environmentalVibriospecies Francis J Santoriello, Paul C Kirchberger, Yann Boucher, Stefan Pukatzki
18 [GO] 2022―Nov―08 C-to-U RNA deamination is the driving force accelerating SARS-CoV-2 evolution Yan Li, Fanghua Hou, Meili Zhou, Xiaoping Yang, Bin Yin, Wenqing Jiang, Huiqing Xu
19 [GO] 2022―Oct―19 A prediction model for COVID-19 liver dysfunction in patients with normal hepatic biochemical parameters Jianfeng Bao, Shourong Liu, Xiao Liang, Congcong Wang, Lili Cao, Zhaoyi Li, et al. (+14)
20 [GO] 2022―Oct―14 Low expression of EXOSC2 protects against clinical COVID-19 and impedes SARS-CoV-2 replication Tobias Moll, Valerie Odon, Calum Harvey, Mark O Collins, Andrew Peden, John Franklin, et al. (+14)
21 [GO] 2022―Aug―12 Efficacy of SARS-CoV-2 vaccination in patients with monoclonal gammopathies: A cross sectional study Eugenia Abella, Macedonia Trigueros, Edwards Pradenas, Francisco Muñoz-Lopez, Francesc Garcia-Pallarols, Randa Ben Azaiz Ben Lahsen, et al. (+17)
22 [GO] 2022―Aug―04 Human milk inhibits some enveloped virus infections, including SARS-CoV-2, in an intestinal model Ikrame Aknouch, Adithya Sridhar, Eline Freeze, Francesca Paola Giugliano, Britt J van Keulen, Michelle Romijn, et al. (+10)
23 [GO] 2022―Jun―09 Correction: Transmembrane protease serine 2 (TMPRSS2) rs75603675, comorbidity and sex are the primary predictors of Covid-19 severity Gonzalo Villapalos-García, Pablo Zubiaur, Rebeca Rivas-Durán, Pilar Campos-Norte, Cristina Arévalo-Román, Marta Fernández-Rico, et al. (+10)
24 [GO] 2022―May―30 Transmembrane protease serine 2 (TMPRSS2) rs75603675, comorbidity, and sex are the primary predictors of COVID-19 severity Gonzalo Villapalos-García, Pablo Zubiaur, Rebeca Rivas-Durán, Pilar Campos-Norte, Cristina Arévalo-Román, Marta Fernández-Rico, et al. (+10)
25 [GO] 2022―May―12 Subgenomic RNA profiling suggests novel mechanism in coronavirus gene regulation and host adaption Lin Lyu, Ru Feng, Mingnan Zhang, Xiaoqing Xie, Yinjing Liao, Yanjiao Zhou, et al. (+4)
26 [GO] 2022―Mar―16 SARS-CoV-2 spike E156G/Δ157-158 mutations contribute to increased infectivity and immune escape Tarun Mishra, Rishikesh Dalavi, Garima Joshi, Atul Kumar, Pankaj Pandey, Sanjeev Shukla, et al. (+2)
27 [GO] 2022―Mar―07 LRR-protein RNH1 dampens the inflammasome activation and is associated with COVID-19 severity Giuseppe Bombaci, Mayuresh Anant Sarangdhar, Nicola Andina, Aubry Tardivel, Eric Chi-Wang Yu, Gillian M Mackie, et al. (+14)
28 [GO] 2022―Mar―07 Monobodies with potent neutralizing activity against SARS-CoV-2 Delta and other variants of concern Taishi Kondo, Kazuhiro Matsuoka, Shun Umemoto, Tomoshige Fujino, Gosuke Hayashi, Yasumasa Iwatani, Hiroshi Murakami
29 [GO] 2022―Feb―15 mRNA COVID-19 vaccine booster fosters B- and T-cell responses in immunocompromised patients Elena Azzolini, Chiara Pozzi, Luca Germagnoli, Bianca Oresta, Nicola Carriglio, Mariella Calleri, et al. (+10)
30 [GO] 2022―Feb―02 Topical TMPRSS2 inhibition prevents SARS-CoV-2 infection in differentiated human airway cultures Wenrui Guo, Linsey M Porter, Thomas WM Crozier, Matthew Coates, Akhilesh Jha, Mikel McKie, et al. (+4)
31 [GO] 2022―Feb―02 Proteomic landscape of SARS-CoV-2- and MERS-CoV-infected primary human renal epithelial cells Aneesha Kohli, Lucie Sauerhering, Sarah K Fehling, Kevin Klann, Helmut Geiger, Stephan Becker, et al. (+4)
32 [GO] 2022―Jan―17 Age-related differences in immune dynamics during SARS-CoV-2 infection in rhesus macaques Emily Speranza, Jyothi N Purushotham, Julia R Port, Benjamin Schwarz, Meaghan Flagg, Brandi N Williamson, et al. (+17)
33 [GO] 2022―Jan―10 Preclinical and randomized phase I studies of plitidepsin in adults hospitalized with COVID-19 Jose F Varona, Pedro Landete, Jose A Lopez-Martin, Vicente Estrada, Roger Paredes, Pablo Guisado-Vasco, et al. (+45)
34 [GO] 2022―Jan―07 Sensitive visualization of SARS-CoV-2 RNA with CoronaFISH Elena Rensen, Stefano Pietropaoli, Florian Mueller, Christian Weber, Sylvie Souquere, Sina Sommer, et al. (+9)
35 [GO] 2021―Dec―03 Exosomes/microvesicles target SARS-CoV-2 via innate and RNA-induced immunity with PIWI-piRNA system Shoeb Ikhlas, Afia Usman, Dongkyeong Kim, Dongsheng Cai
36 [GO] 2021―Nov―30 Microfluidic characterisation reveals broad range of SARS-CoV-2 antibody affinity in human plasma Matthias M Schneider, Marc Emmenegger, Catherine K Xu, Itzel Condado Morales, Georg Meisl, Priscilla Turelli, et al. (+13)
37 [GO] 2021―Nov―11 Elevation in sphingolipid upon SARS-CoV-2 infection: possible implications for COVID-19 pathology Einat B Vitner, Roy Avraham, Boaz Politi, Sharon Melamed, Tomer Israely
38 [GO] 2021―Sep―30 Engineered RNA biosensors enable ultrasensitive SARS-CoV-2 detection in a simple color and luminescence assay Anirudh Chakravarthy, Anirudh Nandakumar, Geen George, Shyamsundar Ranganathan, Suchitta Umashankar, Nishan Shettigar, et al. (+3)
39 [GO] 2021―Sep―09 Autoimmune anti-DNA and anti-phosphatidylserine antibodies predict development of severe COVID-19 Claudia Gomes, Marisol Zuniga, Kelly A Crotty, Kun Qian, Nubia Catalina Tovar, Lawrence Hsu Lin, et al. (+9)
40 [GO] 2021―Aug―05 Integrated human/SARS-CoV-2 metabolic models present novel treatment strategies against COVID-19 Bridget P Bannerman, Jorge Júlvez, Alexandru Oarga, Tom L Blundell, Pablo Moreno, R Andres Floto
41 [GO] 2021―Aug―03 Incomplete antiviral treatment may induce longer durations of viral shedding during SARS-CoV-2 infection Kwang Su Kim, Shoya Iwanami, Takafumi Oda, Yasuhisa Fujita, Keiji Kuba, Taiga Miyazaki, et al. (+2)
42 [GO] 2021―Jul―28 High-dose intravenous immunoglobulins might modulate inflammation in COVID-19 patients María Luisa Rodríguez de la Concepción, Erola Ainsua-Enrich, Esteban Reynaga, Carlos Ávila-Nieto, Jose Ramón Santos, Silvia Roure, et al. (+8)
43 [GO] 2021―Jul―06 A serum proteome signature to predict mortality in severe COVID-19 patients Franziska Völlmy, Henk van den Toorn, Riccardo Zenezini Chiozzi, Ottavio Zucchetti, Alberto Papi, Carlo Alberto Volta, et al. (+12)
44 [GO] 2021―Jun―24 Prognostic accuracy of MALDI-TOF mass spectrometric analysis of plasma in COVID-19 Lucas Cardoso Lazari, Fabio De Rose Ghilardi, Livia Rosa-Fernandes, Diego M Assis, José Carlos Nicolau, Veronica Feijoli Santiago, et al. (+8)
45 [GO] 2021―Mar―16 Phylo-geo-network and haplogroup analysis of 611 novel coronavirus (SARS-CoV-2) genomes from India Rezwanuzzaman Laskar, Safdar Ali
46 [GO] 2021―Feb―16 A systems-based method to repurpose marketed therapeutics for antiviral use: a SARS-CoV-2 case study Mengran Wang, Johanna B Withers, Piero Ricchiuto, Ivan Voitalov, Michael McAnally, Helia N Sanchez, et al. (+3)
47 [GO] 2021―Feb―11 SARS-CoV-2 infection induces protective immunity and limits transmission in Syrian hamsters Prabhuanand Selvaraj, Christopher Z Lien, Shufeng Liu, Charles B Stauft, Ivette A Nunez, Mario Hernandez, et al. (+5)
48 [GO] 2020―Dec―24 Profiling of immune dysfunction in COVID-19 patients allows early prediction of disease progression André F Rendeiro, Joseph Casano, Charles Kyriakos Vorkas, Harjot Singh, Ayana Morales, Robert A DeSimone, et al. (+16)
49 [GO] 2020―Nov―24 Inhibiting the reproduction of SARS-CoV-2 through perturbations in human lung cell metabolic network Hadrien Delattre, Kalesh Sasidharan, Orkun S Soyer
50 [GO] 2020―Jul―23 TMPRSS2 and furin are both essential for proteolytic activation of SARS-CoV-2 in human airway cells Dorothea Bestle, Miriam Ruth Heindl, Hannah Limburg, Thuy Van Lam van, Oliver Pilgram, Hong Moulton, et al. (+9)
 [1] 

50 Results       Page 1


[de][en]

Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.005 sec